Holobiome

Developer of microbiome-based therapeutics for nervous system disorders

placeCambridge, Massachusetts, United States calendar_todayFounded 2015 groups12 employees language holobiome.org

Innovation

5 patent families (1 granted) — focus: Human necessities; filing pace steady. Cited 440 times.

YearFilings
20171
20181
20191
20202
20213
20223
20232
20241
20253
20262

Investor mix

14 investors on record; lead investors include iSelect Fund.

Investor typeCountShare
Venture capital750%
Private equity214%
Accelerator & incubator214%
Other / undisclosed321%
Coming soon